Patent · US Expired

Amplicon in the 20q13 region of human chromosome 20 and uses thereof

US6664057B2 · kind B2 · utility

26Cited by
2References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 28, 2001
Grant dateDec 16, 2003
Priority date
Expiry dateJun 28, 2021

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/156
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

This invention pertains to the field of cancer genetics and cytogenetics. In particular, this invention pertains to the identification of a novel amplicon on human chromosome 20 which is associated with cancer. More particularly this invention pertains to the identification of a novel “amplicon” or genomic nucleic acid in a region of amplification at about 20q13.2 which has been associated with a variety of cancers, particularly breast cancer. The novel amplicon of the invention can be used as a probe specific for this region of 20q13.2 as well as for the diagnosis and prognosis of various cancers. Also provided are kits for screening for the presence and copy number of the novel amplicon of the invention in a sample containing human nucleic acid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.